Related content

A phase II trial of ZD0473 in platinum-pretreated ovarian cancer

By Gore M.E.   Atkinson R.J.   Thomas H.   Cure H.   Rischin D.   Beale P.   Bougnoux P.   Dirix L.   Smit W.M.  

European Journal of Cancer, Vol. 38, Iss. 18, 2002-12 ,pp. : 2416-2420

Elsevier

Access to resources Recommend Favorite

A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma

By Chiorean E.   Dragovich Tomislav   Hamm John   Langmuir Virginia   Kroll Stewart   Jung Donald   Colowick Alan   Tidmarsh George   Loehrer Patrick  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1019-1026

Springer Publishing Company

Access to resources Recommend Favorite

Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors

By Sausville Edward   LoRusso Patricia   Carducci Michael   Carter Judith   Quinn Mary   Malburg Lisa   Azad Nilofer   Cosgrove David   Knight Richard   Barker Peter   Zabludoff Sonya   Agbo Felix   Oakes Patricia   Senderowicz Adrian  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 539-549

Springer Publishing Company

Access to resources Recommend Favorite

A phase I clinical trial of dose escalation of lobaplatin in combination with fixeddose docetaxel for the treatment of human solid tumours that had progressed following chemotherapy

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 67-74

Spandidos Publications

Access to resources Recommend Favorite

A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

By Schelman William   Morgan-Meadows Sherry   Bailey Howard   Holen Kyle   Thomas James   Eickhoff Jens   Brandon Heidi   Oliver Kate   Alberti Dona   Wilding George  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. : 727-733

Springer Publishing Company

Access to resources Recommend Favorite